The first settlers of Hawaii were the most capable sailors of their time, crossing 7,000 kilometers of open ocean to reach ...
The Stanford Cancer Institute has released its 2026 Annual Report, celebrating the collective efforts of Stanford faculty, ...
Karl Deisseroth, MD, PhD, has devoted the better part of two decades of his career to the development and promulgation of optogenetics, which has immeasurably improved scientists’ ability to probe the ...
Stanford is committed to creating a workplace where staff feel supported, connected, and empowered to do meaningful work. As the nature of work continues to evolve, coming together with shared clarity ...
A single treatment of the psychedelic drug ibogaine appeared to provide long-lasting recovery from PTSD, anxiety and depression in a small study of special ops veterans with traumatic brain injury.
Pathology professor Patrick Hsu’s $250,000 prize will accelerate the development of new gene-editing tools and artificial intelligence models that can identify disease-causing mutations.
Maybe your doctor has mentioned them, a friend or family member is taking one — or a growing list of related drugs. The dramatic before-and-after stories of weight loss are everywhere, but so are the ...
When Emmanuel Mignot, MD, PhD, began studying narcolepsy four decades ago, sleep and its disorders were not considered serious subjects of scientific inquiry. His long, curly hair and the fact that he ...
The first randomized, controlled trial for a common childhood eating disorder has shown how therapists and parents can help those struggling with the condition, known as avoidant restrictive food ...
“AI” and “Labubu” aren’t often uttered in the same breath. But on the first day of Stanford Health AI week, Laurah Turner, PhD, keynote speaker at the AI in Medical Education symposium, showed a slide ...
Every spring, Americans dutifully adjust their clocks forward to daylight saving time, and every fall, back to standard time — but no one seems very happy about it. The biannual time shift is not only ...
Two-thirds of Americans living with Alzheimer’s disease today are women. That sobering data point has been cited by the Alzheimer’s Association and others for years but it still tends to catch people ...